Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
May 05 2023 - 6:46AM
Edgar (US Regulatory)
PROSPECTUS
SUPPLEMENT
(To
Prospectus dated January 13, 2023)
Filed
Pursuant to Rule 424(b)(5)
Registration
No. 333-269104
Up
to $4,970,000
Common
Stock
This
prospectus supplement amends and supplements the information in the prospectus, dated January 13, 2023, filed as a part of our registration
statement on Form S-3 (File No. 333-269104), as supplemented by our prospectus supplement dated January 13, 2023, or the Prior Prospectus.
This prospectus supplement should be read in conjunction with the Prior Prospectus, and is qualified by reference thereto, except to
the extent that the information herein amends or supersedes the information contained in the Prior Prospectus. This prospectus supplement
is not complete without, and may only be delivered or utilized in connection with, the Prior Prospectus, and any future amendments or
supplements thereto.
We
filed the Prior Prospectus to register the offer and sale of our common stock, par value $0.0001 per share, from time to time pursuant
to the terms of that certain At The Market Offering Agreement, or the sales agreement, between H.C. Wainwright & Co., LLC, or Wainwright,
acting as the agent, and us. Through the date hereof, we have not sold any shares of common stock under the Sales Agreement pursuant
to the Prior Prospectus.
We
are filing this prospectus supplement to amend the Prior Prospectus to update the amount of shares we are eligible to sell under General
Instruction I.B.6. As a result of these limitations and the current public float of our common stock, and in accordance with the terms
of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $4,970,000
from time to time through Wainwright.
As
of May 5, 2023, the aggregate market value of our outstanding common stock held by non-affiliates, or the public float, was $14,913,275.50,
which was calculated based on 8,061,230 shares of our outstanding common stock held by non-affiliates at a price of $1.85 per
share, the closing price of our common stock on March 10, 2023. During the 12 calendar months prior to, and including, the date of this
prospectus, we have not sold any securities pursuant to General Instruction I.B.6 of Form S-3.
Our
common stock is listed on the Nasdaq Capital Market under the symbol “CING.” On May 4, 2023, the last reported sale price
of our common stock on the Nasdaq Capital Market was $1.09 per share.
NEITHER
THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED
UPON THE ADEQUACY OR ACCURACY OF THIS PROSPECTUS SUPPLEMENT AND THE ACCOMPANYING PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
H.C.
Wainwright & Co.
The
date of this prospectus supplement is May 5, 2023
Cingulate (NASDAQ:CING)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cingulate (NASDAQ:CING)
Historical Stock Chart
From Jul 2023 to Jul 2024